Skip to content


Please Help Us


All donations received will be used to fund research into finding a cure for children who suffer from Cask Gene Mutations and related conditions. ACNRF is endorsed as a Deductible Gift Recipient (DGR) from 21 Aug 2020. Item 1 of the table in section 30-15 of the Income Tax Assessment Act 1997  

“In some ways, that CASK-linked pathology is degenerative in nature provides a positive outlook. Because microcephaly in CASK-linked pathology progresses postnatally, there may be a temporal window when therapeutic intervention might prevent or slow further brain cell loss. Regression, even in adolescence, has also been observed in some cases of MICPCH [119], again offering the tantalizing possibility that a therapeutic approach might prevent such decline under conditions when degeneration is known to progressThe potential benefits of intervention might extend even further given that non-cell-autonomous toxicity could also affect functioning of the remaining neurons; reduction of such toxicity, especially when coupled with high-intensity rehabilitative measures [120], might offer real hope for a positive impact on functional outcomes.”